Literature DB >> 9888580

Aldosterone synthase (CYP11B2) polymorphisms and cardiovascular function.

P C White1, A Hautanen, M Kupari.   

Abstract

In addition to regulating renal sodium resorption and, thus, intravascular volume, aldosterone may have direct effects on the cardiovascular system. We previously identified a polymorphism (-344C/T) in the promoter of the aldosterone synthase (CYP11B2) gene that affects binding of the SF-1 transcription factor and thus might influence gene expression. We found that, whereas this polymorphism has inconsistent associations with levels of aldosterone secretion and blood pressure, the -344C allele is strongly associated with increased left ventricular size and decreased baroreflex sensitivity in healthy individuals. These physiological parameters are cardiovascular risk factors. Indeed, preliminary studies suggest that the -344C allele is also associated with increased risk of myocardial infarction in high risk dyslipidemic males.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9888580     DOI: 10.3109/07435809809032690

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  4 in total

1.  Association of CYP11B2 polymorphisms with metabolic syndrome patients.

Authors:  Young Ree Kim; Sun Hyung Kim; Sung Ha Kang; Hyun Ju Kim; Mi Hee Kong; Seung Ho Hong
Journal:  Biomed Rep       Date:  2014-07-11

Review 2.  Towards Precision Medicine for Hypertension: A Review of Genomic, Epigenomic, and Microbiomic Effects on Blood Pressure in Experimental Rat Models and Humans.

Authors:  Sandosh Padmanabhan; Bina Joe
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

3.  Aldosterone Synthase Gene (CYP11B2) Polymorphism in Korean End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Ji Eun Lee; So Yon Bae; Jeong-Yup Kim; Heui Jung Pyo; Young Joo Kwon
Journal:  Electrolyte Blood Press       Date:  2009-12-31

4.  Association of -344C/T polymorphism in the aldosterone synthase (CYP11B2) gene with cardiac and cerebrovascular events in Chinese patients with hypertension.

Authors:  Lili Wang; Zhi Zhang; Dongxia Liu; Kexin Yuan; Guohua Zhu; Xiaoyong Qi
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.